Share

July 30, 2013; 81 (5) Article

Discontinuation of statin therapy associates with Parkinson disease

A population-based study

Yen-Chieh Lee, Chin-Hsien Lin, Ruey-Meei Wu, Min-Shung Lin, Jou-Wei Lin, Chia-Hsuin Chang, Mei-Shu Lai
First published July 24, 2013, DOI: https://doi.org/10.1212/WNL.0b013e31829d873c
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
540

Share

Article Information

vol. 81 no. 5 410-416
DOI: 
https://doi.org/10.1212/WNL.0b013e31829d873c
PubMed: 
23884037
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received December 16, 2012
  • Accepted in final form April 1, 2013
  • First Published July 24, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Yen-Chieh Lee, MD*,
    2. Chin-Hsien Lin, MD, PhD*,
    3. Ruey-Meei Wu, MD, PhD,
    4. Min-Shung Lin, MD,
    5. Jou-Wei Lin, MD, PhD,
    6. Chia-Hsuin Chang, MD, PhD and
    7. Mei-Shu Lai, PhD
  1. Yen-Chieh Lee, MD*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Chin-Hsien Lin, MD, PhD*,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Ruey-Meei Wu, MD, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Min-Shung Lin, MD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Jou-Wei Lin, MD, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Chia-Hsuin Chang, MD, PhD and
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. This study was supported in part by Taiwan Ministry of Education grant 98HP0021

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Mei-Shu Lai, PhD
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Family Medicine (Y.-C.L., M.-S.L), Cathay General Hospital, Taipei; the Departments of Neurology (C.-H.L., R.-M.W.) and Medicine (C.-H.C.), National Taiwan University Hospital, Taipei; Department of Medicine, College of Medicine (J.-W.L., C.-H.C.), and Institute of Preventive Medicine, College of Public Health (C.-H.C., M.-S.L.), National Taiwan University, Taipei; and Cardiovascular Center (J.-W.L.), National Taiwan University Hospital Yun-Lin Branch, Dou-Liou City, Yun-Lin County, Taiwan.
  1. Correspondence to Dr. Lin: jouweilin{at}yahoo.com.tw or Dr. Chang: chiahsuin123{at}yahoo.com.tw
View Full Text

Article usage

Article usage: July 2013 to March 2023

AbstractFullPdfSource
Jul 2013308621136Highwire
Aug 2013303453115Highwire
Sep 20139201318Highwire
Oct 20135481424Highwire
Nov 2013370169Highwire
Dec 201324437Highwire
Jan 201426566Highwire
Feb 201420867Highwire
Mar 201421325Highwire
Apr 201420236Highwire
May 201428767Highwire
Jun 201413111Highwire
Jul 201414442Highwire
Aug 201412496Highwire
Sep 201413334Highwire
Oct 201415201Highwire
Nov 201412723Highwire
Dec 201413853Highwire
Jan 201512010Highwire
Feb 201512044Highwire
Mar 201525516Highwire
Apr 201511702Highwire
May 20158321Highwire
Jun 201511301Highwire
Jul 201510723Highwire
Aug 20159211Highwire
Sep 201511340Highwire
Oct 20158521Highwire
Nov 20156100Highwire
Dec 20156903Highwire
Jan 20168602Highwire
Feb 20167800Highwire
Mar 20166111Highwire
Apr 20165842Highwire
May 20164511Highwire
Jun 20164721Highwire
Jul 20165922Highwire
Aug 20165900Highwire
Sep 20168300Highwire
Oct 201611700Highwire
Nov 20168501Highwire
Dec 20165911Highwire
Jan 20178101Highwire
Feb 20177400Highwire
Mar 20177900Highwire
Apr 20175811Highwire
May 20174811Highwire
Jun 20175100Highwire
Jul 20174700Highwire
Aug 20175200Highwire
Sep 20175200Highwire
Oct 20174100Highwire
Nov 20175100Highwire
Dec 20174900Highwire
Jan 20187400Highwire
Feb 20188414Highwire
Mar 20189700Highwire
Apr 20189400Highwire
May 20188100Highwire
Jun 20189700Highwire
Jul 20187231Highwire
Aug 20186901Highwire
Sep 20186511Highwire
Oct 20188611Highwire
Nov 201810313Highwire
Dec 20187811Highwire
Jan 20197900Highwire
Feb 20195200Highwire
Mar 20194201Highwire
Apr 20193301Highwire
May 20194010Highwire
Jun 20194721Highwire
Jul 20196413Highwire
Aug 20192811Highwire
Sep 20196200Highwire
Oct 20193510Highwire
Nov 20194010Highwire
Dec 20192700Highwire
Jan 20203700Highwire
Feb 20205911Highwire
Mar 20204201Highwire
Apr 20203220Highwire
May 20203500Highwire
Jun 20201401Highwire
Jul 20202800Highwire
Aug 20202601Highwire
Sep 20204411Highwire
Oct 20204300Highwire
Nov 20205210Highwire
Dec 20206816Highwire
Jan 20212325Highwire
Feb 20213442Highwire
Mar 20216811Highwire
Apr 20217202Highwire
May 20217534Highwire
Jun 20214813Highwire
Jul 20217238Highwire
Aug 20216629Highwire
Sep 20215428Highwire
Oct 20215617Highwire
Nov 20216005Highwire
Dec 20215119Highwire
Jan 202238010Highwire
Feb 20225408Highwire
Mar 202266514Highwire
Apr 20225007Highwire
May 20227103Highwire
Jun 20222400Highwire
Jul 20224002Highwire
Aug 20222700Highwire
Sep 20222511Highwire
Oct 20223201Highwire
Nov 20223702Highwire
Dec 20223402Highwire
Jan 20236810Highwire
Feb 20235511Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles